While it can be caused by benign factors like dehydration, it may also indicate more serious health issues requiring medical evaluation
Cherney has received honoraria from Boehringer Ingelheim-Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, Abbvie, Janssen, Bayer, Prometic, BMS, Maze and Novo-Nordisk and has received operational funding for clinical trials from Boehringer Ingelheim-Lilly, Merck, Janssen, Sanofi, AstraZeneca and Novo-Nordisk
Long-acting, subcutaneously administered, PYY RA are undergoing early phase clinical trials as obesity treatments either alone or in combination with GLP-1 RA (Table 1, NCT02568306 and NCT03574584)
Both platforms support patients for as long as clinically appropriate, with most patients continuing therapy for 12-24 months or longer
Studies show that IGF-1 LR3 effectively increases muscle mass, supports tissue repair, and reduces fat
This guide explores how antioxidants work, their benefits, and how to choose the best supplements